|
Title page |
5 |
|
|
Copyright page |
6 |
|
|
Contents |
7 |
|
|
Contributors |
9 |
|
|
Preface |
11 |
|
|
1: Pacing and Defibrillation: Clinically Relevant Basics for Practice |
13 |
|
|
Anatomy and physiology of the cardiac conduction system |
14 |
|
|
Electrophysiology of myocardial stimulation |
14 |
|
|
Pacing basics |
16 |
|
|
Stimulation threshold |
16 |
|
|
Variations in stimulation threshold |
18 |
|
|
Sensing |
19 |
|
|
Lead design |
21 |
|
|
Bipolar and unipolar pacing and sensing |
25 |
|
|
Left ventricular leads |
25 |
|
|
Pulse generators |
26 |
|
|
Pacemaker nomenclature |
28 |
|
|
Defibrillation basics |
28 |
|
|
Critical mass |
30 |
|
|
Upper limit of vulnerability |
30 |
|
|
Progressive depolarization |
31 |
|
|
Virtual electrode depolarization |
31 |
|
|
Defibrillation theory summary |
33 |
|
|
The importance of waveform |
33 |
|
|
Biphasic waveforms |
34 |
|
|
Phase duration and tilt |
35 |
|
|
Polarity and biphasic waveforms |
36 |
|
|
Mechanism of improved efficacy with biphasic waveforms |
36 |
|
|
Measuring shock dose |
36 |
|
|
Measuring the efficacy of defibrillation |
37 |
|
|
Threshold and dose–response curve |
37 |
|
|
Relationship between defibrillation threshold and dose–response curve |
37 |
|
|
Patient-specific defibrillation threshold and safety margin testing |
38 |
|
|
Clinical role of defibrillation testing at implantation |
39 |
|
|
Management of the patient who fails defibrillation testing |
41 |
|
|
Upper limit of vulnerability to assess safety margin |
45 |
|
|
Drugs and defibrillators |
45 |
|
|
Antitachycardia pacing |
46 |
|
|
References |
47 |
|
|
2: Hemodynamics of Cardiac Pacing: Optimization and Programming to Enhance Cardiac Function |
53 |
|
|
Cardiovascular physiology |
54 |
|
|
Abnormal physiology |
55 |
|
|
Basics of hemodynamic pacing |
55 |
|
|
Chronotropic response |
55 |
|
|
Atrioventricular dissociation and ventriculoatrial conduction |
55 |
|
|
Atrioventricular synchrony |
57 |
|
|
Atrioventricular optimization |
61 |
|
|
Principles of echocardiographic atrioventricular optimization |
64 |
|
|
Atrial mechanical function |
68 |
|
|
Effect of pacing mode on morbidity and mortality |
68 |
|
|
Optimal ventricular pacing sites |
73 |
|
|
Pacing in heart failure |
78 |
|
|
Influence of pacing site |
78 |
|
|
Mechanisms underlying the benefits of left ventricular and biventricular pacing |
79 |
|
|
Left ventricular diastolic function |
82 |
|
|
AV optimization in cardiac resynchronization therapy |
82 |
|
|
Ventricular timing optimization (V-V optimization) |
83 |
|
|
Optimizing site of pacing (LV and/or RV) |
83 |
|
|
Electrical parameters for V-V optimization |
84 |
|
|
QRS vector fusion |
84 |
|
|
Echocardiography for ventricular timing optimization |
87 |
|
|
Clinical approaches to V-V optimization |
87 |
|
|
Other end-points for optimization |
89 |
|
|
Right ventricular function |
89 |
|
|
Cardiac contractility modulation pacing |
90 |
|
|
Ventricular rate regulation |
90 |
|
|
Less common indications for pacing for hemodynamic improvement |
90 |
|
|
Pacing in hypertrophic obstructive cardiomyopathy |
90 |
|
|
Hemodynamic benefits of pacing in neurocardiogenic syndromes |
91 |
|
|
Hemodynamic benefits of pacing in first-degree atrioventricular block |
92 |
|
|
Conclusions |
92 |
|
|
Addendum |
92 |
|
|
References |
92 |
|
|
3: Indications for Pacemakers, ICDs and CRT: Identifying Patients Who Benefit from Cardiac Rhythm Devices |
105 |
|
|
Indications for permanent pacing |
106 |
|
|
Atrioventricular block |
106 |
|
|
Acute myocardial infarction |
112 |
|
|
Chronic bifascicular and trifascicular block |
113 |
|
|
Sinus node dysfunction |
113 |
|
|
Neurally mediated reflex syncope |
116 |
|
|
Tachyarrhythmias |
118 |
|
|
Hypertrophic cardiomyopathy |
119 |
|
|
Congestive heart failure |
119 |
|
|
Pacing after cardiac transplantation |
124 |
|
|
Indications for the implantable cardioverter-defibrillator |
124 |
|
|
Secondary prevention |
125 |
|
|
Primary prevention |
125 |
|
|
Contraindications to implantable cardioverter-defibrillator therapy |
138 |
|
|
Acknowledgement |
139 |
|
|
References |
139 |
|
|
4: Choosing the Device Generator and Leads: Matching the Device with the Patient |
145 |
|
|
Pacemaker selection |
146 |
|
|
Symptomatic bradycardia |
147 |
|
|
Pure sinus node dysfunction |
148 |
|
|
Pure atrioventricular block |
148 |
|
|
Neurocardiogenic syncope and carotid sinus hypersensitivity |
148 |
|
|
Choosing specific programmable options |
148 |
|
|
Choosing the rate-adaptive sensor |
148 |
|
|
Choosing the lead or leads |
148 |
|
|
Threshold reduction |
149 |
|
|
Lead polarity |
149 |
|
|
Electrode design |
151 |
|
|
Lead conductor |
151 |
|
|
Lead insulation |
151 |
|
|
Lead diameter |
152 |
|
|
Compatibility of lead and pulse generator |
153 |
|
|
Epicardial leads |
153 |
|
|
Resources for lead performance and survival data |
154 |
|
|
Generator and lead selection in defibrillators |
156 |
|
|
Lead design considerations for ICD leads |
156 |
|
|
Programmable waveforms |
161 |
|
|
Dual-chamber or single-chamber ICD? |
161 |
|
|
Factors favoring single-chamber defibrillators |
161 |
|
|
Factors favoring dual-chamber defibrillators |
161 |
|
|
Specific device and lead features influencing selection |
162 |
|
|
Conclusions |
166 |
|
|
References |
166 |
|
|
5: Implanting and Extracting Cardiac Devices: Technique and Avoiding Complications |
169 |
|
|
Implantation facility |
170 |
|
|
Anesthesia |
170 |
|
|
The pulse generator pocket |
171 |
|
|
Venous approaches |
172 |
|
|
Axillary (extrathoracic subclavian) approach |
172 |
|
|
Subclavian approach |
177 |
|
|
Cephalic approach |
177 |
|
|
Jugular approach |
177 |
|
|
Iliac vein approach |
178 |
|
|
Ventricular lead placement |
178 |
|
|
Coronary sinus lead placement |
187 |
|
|
Coronary sinus cannulation |
188 |
|
|
Coronary sinus venography |
193 |
|
|
Securing permanent leads |
201 |
|
|
Dual-chamber pulse generator implantation |
201 |
|
|
Measurement of pacing and sensing thresholds |
204 |
|
|
Determination of pacing threshold |
205 |
|
|
Determination of sensing threshold |
206 |
|
|
Epicardial systems |
208 |
|
|
Hardware adaptations |
208 |
|
|
Special considerations in pediatric patients |
210 |
|
|
Device implantation after cardiac transplantation |
214 |
|
|
Hospital stay after implantation |
215 |
|
|
Pulse generator replacement |
215 |
|
|
Post-implant order set |
217 |
|
|
Homegoing instructions |
217 |
|
|
Lead extraction |
217 |
|
|
Indications for lead extraction |
217 |
|
|
Facility requirements for lead extraction |
221 |
|
|
Outcomes of lead extraction |
221 |
|
|
Complications of lead extraction |
221 |
|
|
Extraction techniques |
222 |
|
|
References |
227 |
|
|
6: Implant-Related Complications: Relevant Anatomy and an Approach for Prevention |
231 |
|
|
Complications related directly to the implant procedure |
232 |
|
|
Lead dislodgement |
232 |
|
|
Pneumothorax |
235 |
|
|
Lead perforation |
237 |
|
|
Pericarditis |
240 |
|
|
Arrhythmias |
240 |
|
|
Pulse generator pocket complications |
241 |
|
|
Pain |
242 |
|
|
Inadvertent left ventricular lead placement |
244 |
|
|
Thrombosis |
244 |
|
|
Loose connector block connection |
246 |
|
|
Lead damage |
246 |
|
|
Infection |
247 |
|
|
Abandoned and nonfunctioning, noninfected leads |
250 |
|
|
Twiddler’s syndrome |
252 |
|
|
New symptoms secondary to pacemaker placement |
257 |
|
|
Extracardiac stimulation |
257 |
|
|
Pacemaker syndrome |
257 |
|
|
Tricuspid regurgitation |
257 |
|
|
Battery depletion |
258 |
|
|
Implant or hardware-related complications that may result in recurrence of preimplantation symptoms (see also Chapter 10: Troubleshooting) |
258 |
|
|
Loss of circuit integrity |
258 |
|
|
Lead fracture and insulation defect |
260 |
|
|
Exit block |
260 |
|
|
References |
264 |
|
|
7: Timing Cycles |
267 |
|
|
Basic approach |
268 |
|
|
Pacing modes |
269 |
|
|
Atrial inhibited pacing |
269 |
|
|
Single-chamber triggered-mode pacing |
271 |
|
|
Rate-modulated pacing |
271 |
|
|
Atrioventricular sequential, ventricular inhibited pacing (DVI) |
273 |
|
|
Atrioventricular sequential, non-P-synchronous pacing with dual-chamber sensing (DDI) |
273 |
|
|
Atrioventricular sequential, non-P-synchronous, rate-modulated pacing with dual-chamber sensing (DDIR) |
274 |
|
|
Atrial synchronous (P-tracking/P-synchronous) pacing (VDD) |
274 |
|
|
Dual-chamber pacing and sensing with inhibition and tracking (DDD) |
274 |
|
|
Portions of pacemaker timing cycles |
276 |
|
|
Atrioventricular interval |
276 |
|
|
Comparison of atrial with ventricular-based timing |
280 |
|
|
Dual-chamber rate-modulated pacemakers: effect on timing cycles |
284 |
|
|
Mode switching |
288 |
|
|
Avoiding atrial pace/sense competition |
288 |
|
|
Timing components of ventricular avoidance pacing algorithms |
290 |
|
|
Endless-loop tachycardia |
291 |
|
|
Timing cycles with algorithms responding to sudden bradycardia |
292 |
|
|
Timing cycles unique to biventricular pacing |
293 |
|
|
Timing cycles in ICDs |
299 |
|
|
Initial electrocardiographic interpretation |
300 |
|
|
Response to magnet application |
301 |
|
|
Single-chamber pacemakers |
303 |
|
|
Dual-chamber pacemakers |
304 |
|
|
Biventricular paced electrocardiogram: position, adequacy, and timing |
308 |
|
|
Characteristic electrocardiographic patterns with specific lead locations |
311 |
|
|
Timing intervals and the ECG |
314 |
|
|
Electrocardiographic considerations in the patient not responding to CRT |
328 |
|
|
Conclusions |
328 |
|
|
References |
328 |
|
|
8: Programming: Maximizing Benefit and Minimizing Morbidity Programming |
331 |
|
|
Programmers |
332 |
|
|
Pacemaker programming |
332 |
|
|
Interrogation |
333 |
|
|
Emergency programming |
333 |
|
|
Programmed parameters |
333 |
|
|
Measured data |
334 |
|
|
Specific programmable parameters to consider in all patients |
334 |
|
|
Unexpected programming |
362 |
|
|
Programming during routine follow-up |
369 |
|
|
Defibrillator programming |
372 |
|
|
Implantable cardioverter-defibrillator sensing |
374 |
|
|
Implantable cardioverter-defibrillator detection |
378 |
|
|
SVT-VT discriminators |
385 |
|
|
Ventricular therapies |
402 |
|
|
Atrial defibrillators: detection and therapies |
405 |
|
|
Optimizing programming |
406 |
|
|
Cardiac resynchronization programming |
407 |
|
|
Algorithms to promote continuous tracking |
407 |
|
|
Algorithms to manage premature ventricular complexes |
410 |
|
|
Algorithms to manage atrial fibrillation |
411 |
|
|
Device-based optimization for cardiac resynchronization |
411 |
|
|
Conclusions |
412 |
|
|
References |
413 |
|
|
9: Sensor Technology for Rate-Adaptive Pacing and Hemodynamic Optimization |
419 |
|
|
Indications for rate-adaptive pacing |
420 |
|
|
Sensors available for rate-adaptive pacing |
420 |
|
|
Activity sensors |
421 |
|
|
Minute ventilation sensors |
423 |
|
|
SonR sensor (previously called peak endocardial acceleration sensor) |
423 |
|
|
Right ventricular impedance-based sensor |
424 |
|
|
Stimulus-T or QT, sensing pacemaker |
426 |
|
|
Other sensors |
426 |
|
|
Dual-sensor rate-adaptive pacing |
427 |
|
|
Sensor applications for hemodynamic management |
430 |
|
|
Programming |
430 |
|
|
Programmable parameters |
432 |
|
|
Rate-adaptive pacing with cardiac resynchronization devices |
436 |
|
|
AV and V-V timing |
436 |
|
|
Future of rate-adaptive sensors |
437 |
|
|
References |
437 |
|
|
10: Troubleshooting: Interpreting Diagnostic Information to Ensure Appropriate Function |
439 |
|
|
Pacemaker troubleshooting |
440 |
|
|
Clinical assessment |
440 |
|
|
Identifying the pulse generator |
441 |
|
|
Electrocardiographic interpretation |
442 |
|
|
Lead integrity |
442 |
|
|
Pulse generators |
444 |
|
|
Clinical troubleshooting |
444 |
|
|
Diagnostic features |
451 |
|
|
Unexpected device failure |
451 |
|
|
Operative evaluation of pacing systems |
452 |
|
|
Focused troubleshooting |
452 |
|
|
Failure to capture |
453 |
|
|
Pseudo-malfunctions |
464 |
|
|
Failure to pace (no output) |
466 |
|
|
Undersensing |
470 |
|
|
Alteration in programmed pacing rate |
474 |
|
|
New symptoms after pacemaker implantation |
476 |
|
|
ICD troubleshooting |
484 |
|
|
Diagnostic tools for ICD troubleshooting |
484 |
|
|
Evaluating appropriateness of delivered therapy |
488 |
|
|
Determining if shocks for VT are necessary |
518 |
|
|
Approach to the patient with frequent shocks |
522 |
|
|
Unsuccessful shocks |
523 |
|
|
Failure to deliver or delayed therapy: underdetection and undersensing |
527 |
|
|
Troubleshooting ICD lead failure |
533 |
|
|
Troubleshooting cardiac resynchronization devices |
545 |
|
|
Failure to respond to resynchronization pacing |
545 |
|
|
Troubleshooting other problems in CRT systems |
554 |
|
|
References |
558 |
|
|
11: Radiography of Implantable Devices |
565 |
|
|
Introduction |
566 |
|
|
Pulse generators |
566 |
|
|
Other types of pulse generators |
568 |
|
|
Leads |
570 |
|
|
Pacemaker leads |
572 |
|
|
Transvenous atrial leads |
576 |
|
|
Transvenous ventricular leads |
579 |
|
|
Epicardial leads |
584 |
|
|
ICD leads |
584 |
|
|
Epicardial ICD leads |
584 |
|
|
Transvenous ICD leads |
584 |
|
|
Coronary venous leads |
589 |
|
|
Miscellaneous considerations |
595 |
|
|
Conclusions |
597 |
|
|
References |
600 |
|
|
12: Electromagnetic Interference: Sources, Recognition, and Management |
603 |
|
|
Pacemaker responses to noise |
605 |
|
|
Asynchronous pacing |
605 |
|
|
Mode resetting (power-on reset, or electrical reset) |
609 |
|
|
Environmental electromagnetic interference |
610 |
|
|
References |
623 |
|
|
13: Follow-up |
625 |
|
|
Requirements for a device follow-up clinic |
626 |
|
|
Space |
626 |
|
|
Personnel |
626 |
|
|
Equipment |
627 |
|
|
Pacemaker follow-up |
628 |
|
|
Trans-telephonic monitoring |
628 |
|
|
Equipment |
628 |
|
|
Trans-telephonic monitoring sequence |
629 |
|
|
Internet-based remote monitoring |
630 |
|
|
Pacemaker clinic follow-up visit |
630 |
|
|
ICD follow-up |
638 |
|
|
Assessment of the patient’s clinical status |
638 |
|
|
Pulse generator assessment |
638 |
|
|
Capacitor status |
640 |
|
|
Assessing lead function |
642 |
|
|
Defibrillation efficacy assessment |
643 |
|
|
Medications |
644 |
|
|
Strategies to minimize shocks |
646 |
|
|
CRT follow-up specifics |
646 |
|
|
Remote patient monitoring |
646 |
|
|
Medical advisories and recalls |
652 |
|
|
Lifestyle and personal concerns |
656 |
|
|
Psychologic issues encountered following device implantation |
657 |
|
|
Withdrawal of device support |
658 |
|
|
Conclusions |
658 |
|
|
References |
658 |
|
|
Index |
663 |
|